News
- KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™December 21, 2017 - 8:03 a.m.
- KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in HorsesDecember 4, 2017 - 8:03 a.m.
- Kindred Biosciences Announces Third Quarter 2017 Financial ResultsNovember 7, 2017 - 4:03 p.m.
Kindred Biosciences' Second Quarter 2018 Financial Results (Replay)
08/09/18 at 4:30 p.m. ET
Thursday, August 9, 2018 4:30 p.m. ET
KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™
December 21, 2017
SAN FRANCISCO, Dec. 21, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses
December 4, 2017
SAN FRANCISCO, Dec. 4, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces Third Quarter 2017 Financial Results
November 7, 2017
SAN FRANCISCO, Nov. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Announce Third Quarter 2017 Financial Results
October 11, 2017
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference
October 5, 2017
SAN FRANCISCO, Oct. 5, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
September 11, 2017
SAN FRANCISCO, Sept. 11, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences to Present at Upcoming Investor Conferences
August 30, 2017
SAN FRANCISCO, Aug. 30, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences Announces Second Quarter 2017 Financial Results
August 7, 2017
SAN FRANCISCO, Aug. 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting
August 4, 2017
SAN FRANCISCO, Aug. 4, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Announce Second Quarter 2017 Financial Results
July 24, 2017
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
KindredBio Announces Pricing of Public Offering
July 12, 2017
SAN FRANCISCO, July 12, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
KindredBio Announces Proposed Public Offering of Common Stock
July 11, 2017
SAN FRANCISCO, July 11, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences Announces Acquisition of Kansas Manufacturing Plant and Execution of Commercial Manufacturing Agreement for Zimeta
June 26, 2017
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences Added to the Russell 2000 Index
June 15, 2017
SAN FRANCISCO, June 15, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences to Present Data from Six Studies at the 2017 American College of Veterinary Internal Medicine Conference
May 30, 2017
SAN FRANCISCO, May 30, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Present at 7th Annual LD Micro Invitational
May 24, 2017
SAN FRANCISCO, May 24, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces First Quarter 2017 Financial Results
May 3, 2017
SAN FRANCISCO, May 3, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI...
Kindred Biosciences Announces Initiation of Enrollment in Pivotal Effectiveness Trial of Zimeta Oral for the Control of Fever in Horses
May 1, 2017
SAN FRANCISCO, May 1, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KI...
Kindred Biosciences to Announce First Quarter 2017 Financial Results
April 24, 2017
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences to Present at 2017 Jefferies Animal Health Summit
March 16, 2017
SAN FRANCISCO, March 16, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ:...
Kindred Biosciences Announces Global Sponsorship of International Society of Equine Locomotor Pathology
March 7, 2017
SAN FRANCISCO, March 7, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: ...
Kindred Biosciences Announces Fourth Quarter and Year-End 2016 Financial Results
March 1, 2017
SAN FRANCISCO, March 1, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NAS...
Kindred Biosciences to Announce Fourth Quarter and Year-End 2016 Financial Results
February 21, 2017
Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m...
Kindred Biosciences Receives Early Approval of Effectiveness Technical Section from FDA for Mirataz™ New Animal Drug Application
February 6, 2017
SAN FRANCISCO, Feb. 6, 2017 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...